Kostic Tatjana S, Andric Silvana A, Stojilkovic Stanko S
Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-4510, USA.
Mol Endocrinol. 2004 Feb;18(2):458-70. doi: 10.1210/me.2003-0015. Epub 2003 Nov 20.
It is generally accepted that G protein-coupled receptors stimulate soluble guanylyl cyclase (sGC)-mediated cGMP production indirectly, by increasing nitric oxide (NO) synthase activity in a calcium- and kinase-dependent manner. Here we show that normal and GH(3) immortalized pituitary cells expressed alpha(1)beta(1)-sGC heterodimer. Activation of adenylyl cyclase by GHRH, pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and forskolin increased NO and cGMP levels, and basal and stimulated cGMP production was abolished by inhibition of NO synthase activity. However, activators of adenylyl cyclase were found to enhance this NO-dependent cGMP production even when NO was held constant at basal levels. Receptor-activated cGMP production was mimicked by expression of a constitutive active protein kinase A and was accompanied with phosphorylation of native and recombinant alpha(1)-sGC subunit. Addition of a protein kinase A inhibitor, overexpression of a dominant negative mutant of regulatory protein kinase A subunit, and substitution of Ser(107)-Ser(108) N-terminal residues of alpha(1)-subunit with alanine abolished adenylyl cyclase-dependent cGMP production without affecting basal and NO donor-stimulated cGMP production. These results indicate that phosphorylation of alpha(1)-subunit by protein kinase A enlarges the NO-dependent sGC activity, most likely by stabilizing the NO/alpha(1)beta(1) complex. This is the major pathway by which adenylyl cyclase-coupled receptors stimulate cGMP production.
一般认为,G蛋白偶联受体通过以钙和激酶依赖性方式增加一氧化氮(NO)合酶活性,间接刺激可溶性鸟苷酸环化酶(sGC)介导的cGMP生成。在此我们表明,正常和GH(3)永生化垂体细胞表达α(1)β(1)-sGC异二聚体。生长激素释放激素(GHRH)、垂体腺苷酸环化酶激活多肽、血管活性肠肽和福斯可林激活腺苷酸环化酶可增加NO和cGMP水平,抑制NO合酶活性可消除基础和刺激后的cGMP生成。然而,即使NO保持在基础水平不变,也发现腺苷酸环化酶激活剂可增强这种依赖NO的cGMP生成。组成型活性蛋白激酶A的表达可模拟受体激活的cGMP生成,并伴有天然和重组α(1)-sGC亚基的磷酸化。添加蛋白激酶A抑制剂、过表达调节蛋白激酶A亚基的显性负突变体以及将α(1)-亚基的Ser(107)-Ser(108) N端残基替换为丙氨酸,可消除依赖腺苷酸环化酶的cGMP生成,而不影响基础和NO供体刺激的cGMP生成。这些结果表明,蛋白激酶A对α(1)-亚基的磷酸化扩大了依赖NO的sGC活性,很可能是通过稳定NO/α(1)β(1)复合物实现的。这是腺苷酸环化酶偶联受体刺激cGMP生成的主要途径。